Edition:
India

SSY Group Ltd (2005.HK)

2005.HK on Hong Kong Stock

4.96HKD
18 Jan 2018
Change (% chg)

-- (--)
Prev Close
HK$4.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
5,234,915
52-wk High
HK$5.28
52-wk Low
HK$2.42

Chart for

About

SSY Group Limited is an investment holding company principally engaged in the research, development, manufacture and sale of pharmaceutical products. Its products include finished medicines of intravenous infusion solution for hospitals and distributors, bulk pharmaceuticals and medical materials. The Company’s subsidiaries... (more)

Overall

Beta: 0.36
Market Cap(Mil.): HK$10,143.76
Shares Outstanding(Mil.): 2,849.37
Dividend: 0.03
Yield (%): 1.69

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.58
EPS (TTM): -- -- --
ROI: -- 14.84 10.60
ROE: -- 16.32 14.19

BRIEF-SSY Group Updates on Product Development

* SSY GROUP-OBTAINED APPROVAL FOR DRUG PRODUCTION & REGISTRATION FOR SODIUM ACETATE RINGER'S INJECTION (500ML) FROM CHINA FOOD & DRUG ADMINISTRATION​ Source text for Eikon: Further company coverage:

11 Dec 2017

BRIEF-SSY Group obtains production approvals from FDA of Hebei province

* Obtained production approvals for seven bulk pharmaceuticals as approved from food and drug administration of Hebei province

30 Aug 2017

BRIEF-SSY Group posts HY profit attributable of HK$288 mln

* HY revenue of HK$1,325 million, representing an increase of 19.5 percent

23 Aug 2017

BRIEF-SSY Group expects HY profit attributable to increase

* Profit attributable for hy expected to increase and record an increase of not less than 30 pct

01 Aug 2017

Earnings vs. Estimates